A Review on: Post-Covid Complications
Journal of Current Pharma Research
; 13(1):18-26, 2021.
Article
in English
| ProQuest Central | ID: covidwho-2169263
ABSTRACT
The "Coronavirus disease 2019" has resulted by infecting millions of people globally and indirectly affect the individuals through disruption of daily routine. Since the diagnosis of index case, linked to sea food and wet animal wholesale market in Wuhan, China, in December 2019.The discharge of this virus has spread worldwide and has threatened the whole world and considered as pandemic recently. World Health Organization (WHO] has declared COVID-19 Pandemic on March 2020. Long term health outcomes of COVID-19 have been reported with the similar diseases from other coronaviruses. "Middle East Respiratory Syndrome" and "Severe Acute Respiratory Syndrome". Major adverse outcomes was found to affect different body systems in humans (neurological system, GIT, hepatic an renal system, CVS, muscle pain, mental health outcomes, pulmonary outcomes, fungal infection and many more chronic symptoms were observed in patients in Post-COVID-19 recovery. Globally the community is focusing on trialing COVID-19 vaccines and its treatment, and its equally important to focus on recovered patients an possible events faced by patients in post recovery period. Thus this article emphasizes long-term COVID-19 health complications in patients during Post recovery period.
Search on Google
Collection:
Databases of international organizations
Database:
ProQuest Central
Topics:
Long Covid
Language:
English
Journal:
Journal of Current Pharma Research
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS